Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers
Study Details
Study Description
Brief Summary
The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures and assess their usefulness as diagnostic biomarkers for AKI and the relationship between the selected RNA based biomarker panel and clinicopathological changes of patients.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Percutaneous nephrolithotomy patients suffering of pelvic renal stones underwent Percutaneous nephrolithotomy |
Procedure: Percutaneous nephrolithotomy
Endoscopic stone Extraction from the kidney by making a puncture and dilate a tract direct into the kidney through muscle wall and renal parenchyma
Other Names:
|
Active Comparator: Extracorporeal Shock Wave Lithotripsy patients suffering of pelvic renal stones underwent Extracorporeal Shock Wave Lithotripsy |
Procedure: Extracorporeal Shock Wave Lithotripsy
Using Shock waves from outside the body targeted at a kidney stone causing the stone to fragment. The stones are broken into tiny pieces.
Other Names:
|
No Intervention: control group Healthy volunteers with negative history of renal stones or renal impairment to measure the level of urinary markers in their urine samples |
Outcome Measures
Primary Outcome Measures
- Evaluation of renal damage after PCNL and ESWL using novel RNA based Biomarkers [Before the procedure by 2hours and after the procedure by 2 and 24 hours]
Evaluation of kidney injury after procedures PCNL and ESWL by measuring the change of the level of novel non-coding lnc-RNA profile in urine
Eligibility Criteria
Criteria
Inclusion Criteria:
- Inclusion criteria for patients :
-
Patients undergoing treatment for a stone(s) located in the kidney less than 2 cm
-
Radiopaque stone
-
Able and willing to give informed consent
Inclusion criteria for Healthy volunteers
-
No history of kidney or stone disease
-
Asymptomatic
-
No indwelling ureteral stent
-
Willing to provide medical history information
-
Able and willing to give informed consent
Exclusion Criteria:
- Exclusion criteria for patients
-
Active urinary tract infection
-
Bleeding disorder
-
Chronic renal failure (eGFR<30)
-
Ureteral stone
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Urology Department, Faculty of Medicine, Ain Shams University | Cairo | Egypt | 11884 |
Sponsors and Collaborators
- Ain Shams University
- Science,Technology & Innovation Funding Authority
Investigators
- Principal Investigator: waleed Mousa, Urology Department, Ain Shams University, Abassia, Cairo
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- FMASU R 77/ 2021